This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Tjernström, F Articles by Sturfelt, G Search for Related Content PubMed PubMed Citation Articles by Tjernström, F Articles by Sturfelt, G Pubmed/NCBI databases Substance via MeSH Medline Plus Health Information Lupus Social Bookmarking                         What's this?

Synergetic effect between interleukin-1 receptor antagonist allele (IL1RN*2) and MHC class II (DR17,DQ2) in determining susceptibility to systemic lupus erythematosus

Department of Rheumatology, Lund University Hospital, Lund, Sweden

G Hellmer

Department of Medical Microbiology, Lund University Hospital, Lund, Sweden

O Nived

Department of Rheumatology, Lund University Hospital, Lund, Sweden

L Truedsson

Department of Medical Microbiology, Lund University Hospital, Lund, Sweden

G Sturfelt

Department of Rheumatology, Lund University Hospital, Lund, Sweden

We investigated whether IL1RN alleles separately or in combination with MHC class II variants, contribute to susceptibility to SLE and to analysed if IL1RN alleles are markers of disease severity.

We investigated 81 patients from a defined area in southern Sweden diagnosed between 1981–1992 and 10 consecutive Caucasian families with multiple cases of SLE. As control group 189 healthy blood donors was used. PCR amplification of defined gene sequences was used in determining the IL1RN polymorphism as well as the MHC class II variants. The IL-1RA levels were measured by an immunoassay.

We found an increased frequency of IL1RN*2 in both the epidemiological cohort and in the multicase families (P < 0.01). Alone IL1RN*2 and MHC class II (DR17,DQ2) separately increased the SLE risk moderately. The occurrence of IL1RN*2 and MHC class II variants DR17 and DQ2 together increased the risk to develop SLE by a sevenfold. The IL-1RA gene polymorphism did not correlate with disease severity or with renal involvement. We found an association between IL1RN*1 and arthritis (P < 0.001). Serum level of IL-1RA did not correspond to any specific IL1RN allele.

An increased frequency of IL1RN*2 suggests the presence of a gene, implemented in SLE-susceptibility, in the IL1RN region of chromosome 2. IL1RN*2 and specific variants of MHC class II act in synergy to increase disease susceptibility. IL1RN*1 may be a marker of risk for development of arthritis.

Key Words: SLE • MHC • IL-1RA • genetics • microsatellite

Lupus, Vol. 8, No. 2, 103-108 (1999)
DOI: 10.1191/096120399678847560


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				J R Zelefsky, C J Taylor, M Srinivasan, S Peacock, R S Goodman, T Key, P G Watson, and E T Cunningham HLA-DR17 and Mooren's ulcer in South India Br J Ophthalmol, February 1, 2008; 92(2): 179 - 181. [Abstract] [Full Text] [PDF]

				T. J. DeGraba Immunogenetic Susceptibility of Atherosclerotic Stroke: Implications on Current and Future Treatment of Vascular Inflammation Stroke, November 1, 2004; 35(11_suppl_1): 2712 - 2719. [Abstract] [Full Text] [PDF]

				F. McGarry, J. Neilly, N. Anderson, R. Sturrock, and M. Field A polymorphism within the interleukin 1 receptor antagonist (IL-1Ra) gene is associated with ankylosing spondylitis Rheumatology, December 1, 2001; 40(12): 1359 - 1364. [Abstract] [Full Text] [PDF]

				W. P Arend and C. J Guthridge Biological role of interleukin 1 receptor antagonist isoforms Ann Rheum Dis, November 1, 2000; 59(90001): i60 - 64. [Abstract] [Full Text] [PDF]